NEW YORK & PETACH TIKVAH, Israel -- -- BrainStorm Cell Therapeutics , a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that it has signed a definitive agreement with the Mayo Clinic in Rochester, Minnesota to conduct its Phase II clinical trial of NurOwn in amyotrophic lateral sclerosis , pending ... (more)
http://ift.tt/1fmQUFD
http://ift.tt/1fmQUFD
No comments:
Post a Comment